Mark Steven Lemel, MD Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 316 Chestnut St Ste 2, Brevard, NC 28712 Phone: 828-884-2055 Fax: 828-884-2834 |
David Locke Glenn Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Hospital Dr, Brevard, NC 28712 Phone: 828-883-5330 Fax: 828-883-5242 |
Dr. W. Mcfarland Bridges Ii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 89 Hospital Dr, Brevard, NC 28712 Phone: 828-862-6368 Fax: 828-885-5742 |
James A Hoffmeister, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 89 Hospital Dr, Suite D, Brevard, NC 28712 Phone: 828-862-6368 Fax: 828-885-5742 |
News Archive
An estimated 50 million adults in the United States suffer from arthritis. According to the Centers for Disease Control, one of the best ways to combat the onset of arthritis as well as to control pain and improve function is through exercise.
EndoChoice Inc. maker of the Fuse Full Spectrum Endoscopy system that allows doctors to see more of the GI tract than ever before today announced the launch of FuseColonoscopy.org to provide patients with the latest information on colorectal cancer screening.
The Michigan State Medical Society (MSMS) Foundation mobilized hundreds of volunteers this month in its 13th annual statewide effort to help provide basic comforts to those living in Michigan's domestic violence shelters.
Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
The study carried out by the Complutense University of Madrid (Spain) –UCM – is the first to evaluate retinal damage using tablets with LED screens available in the market with living animals.
› Verified 4 days ago